Walk any health and wellness aisle, physical or digital, and the claims blur into one another. Supports immunity. Aids recovery. Promotes balance. Optimises performance. These phrases are everywhere, and they are everywhere for a reason: they are almost impossible to be wrong about.
That is usually presented as the clever move. Say enough to sell, stay vague enough to stay compliant. It is worth noticing what it costs.
An unfalsifiable claim is also an undifferentiating one
If a claim cannot be shown to be false, it also cannot be owned. Any competitor can make the identical statement tomorrow, at no cost, with no substantiation, and no consumer will be able to tell the two apart. The vagueness that protects you from challenge is the same vagueness that makes you interchangeable.
This is the trap the category has built for itself. An entire market has converged on a shared vocabulary of soft outcome language, and then spends heavily on design, influencer spend and packaging to create the differentiation the words no longer provide.
Evidence changes the maths. Not because a citation persuades anyone — most buyers will never read the study — but because evidence lets you say something specific, and specificity is the only claim territory a competitor cannot occupy for free.
What evidence buys, precisely
It buys three things.
A defensible boundary. You know what you can say and what you cannot. That sounds like a limitation until you have watched a brand rebuild its entire communications architecture after a regulator disagreed with a single line on a label.
A reason for the specific. "Formulated at the dose used in the trial" is a sentence most competitors cannot write. It is more interesting than "clinically proven," which has been diluted into meaninglessness, and it is far more interesting than "supports wellbeing."
A structure for saying less. Once you know which two claims you can actually stand behind, the case for dropping the other nine becomes obvious. Most wellness brands are not under-claiming. They are claiming so much that nothing lands.
What it does not buy
Evidence does not buy permission. This is the most common and most expensive misunderstanding in the category.
In Australia, the line between a therapeutic claim and a wellness claim is drawn by the regulator, not by the strength of your data. Holding a well-conducted study does not entitle you to state a therapeutic outcome. Products making therapeutic claims sit in a different regulatory class with different obligations, and the distinction is determined by what you say, not by what you believe you can support.
Brands routinely get this backwards. They commission research, feel emboldened, and start writing sentences the evidence supports but the framework does not permit. The exposure lives in the claim, not in the product.
The audit that changes the brief
Before any positioning work on a wellness brand, we run the same exercise. Take every claim the brand currently makes — website, packaging, sales deck, founder interviews, the lot — and sort each one into three piles.
Substantiated. There is evidence behind this, and it is evidence about this formulation at this dose, not about an ingredient in general.
Category convention. Everyone says it. Nobody substantiates it. It is inherited, not chosen.
Aspiration. Someone would like it to be true and it has quietly migrated into the copy.
The first pile is almost always small — two or three items. The second is almost always enormous. Founders find this uncomfortable, and it is the single most useful hour of the engagement, because the small pile is the brand. Everything in the second pile is shared property. Everything in the third is a liability with a delay on it.
Restraint reads as confidence
There is a commercial argument here that has nothing to do with compliance.
Buyers in health and wellness are more sceptical than they were a decade ago, and their scepticism is well earned. In that environment, a brand that says three things carefully signals something a brand saying eleven things loudly cannot: that it knows the difference between what it has established and what it hopes.
That signal is not decoration. It is the proposition. In a category where the default is to claim everything, the brand willing to claim less — and to be precise about what remains — is making the only genuinely differentiated move available.
The constraint was never the problem. Treating it as one is.